These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 24124154
1. Immunophenotypic characterization of T-cell prolymphocytic leukemia. Chen X, Cherian S. Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154 [Abstract] [Full Text] [Related]
2. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia. Gujral S, Polampalli S, Badrinath Y, Kumar A, Subramanian PG, Nair R, Sengar M, Nair C. Indian J Cancer; 2010 Nov; 47(2):189-93. PubMed ID: 20448385 [Abstract] [Full Text] [Related]
3. Chronic lymphatic leukemias of T and NK cell type. Kingreen D, Siegert W. Leukemia; 1997 Apr; 11 Suppl 2():S46-9. PubMed ID: 9178839 [Abstract] [Full Text] [Related]
4. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia. Paul RN, Alizadeh L, Ajayi OI, Karpurapu H, Ganesan C, Taddesse-Heath L, Aggarwal A. Acta Haematol; 2012 Apr; 127(4):235-43. PubMed ID: 22517037 [Abstract] [Full Text] [Related]
5. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment. Collignon A, Wanquet A, Maitre E, Cornet E, Troussard X, Aurran-Schleinitz T. Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286 [Abstract] [Full Text] [Related]
9. B- and T-cell prolymphocytic leukemia: antibody approaches. Dearden C. Hematology Am Soc Hematol Educ Program; 2012 Apr; 2012():645-51. PubMed ID: 23233647 [Abstract] [Full Text] [Related]
10. Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia. Sun Y, Tang G, Hu Z, Thakral B, Miranda RN, Medeiros LJ, Wang SA. J Clin Pathol; 2018 Apr; 71(4):309-315. PubMed ID: 28821581 [Abstract] [Full Text] [Related]
11. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype. Sugimoto T, Imoto S, Matsuo Y, Kojima K, Yasukawa M, Murayama T, Kohfuku J, Mizuno I, Yakushijin K, Sada A, Nishimura R, Koizumi T. Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117 [Abstract] [Full Text] [Related]
12. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement. Hsi AC, Robirds DH, Luo J, Kreisel FH, Frater JL, Nguyen TT. Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835 [Abstract] [Full Text] [Related]
13. T gamma lymphocytosis and T cell chronic leukemias. Berliner N. Hematol Oncol Clin North Am; 1990 Apr; 4(2):473-87. PubMed ID: 2182603 [Abstract] [Full Text] [Related]
14. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified. Kawamoto K, Miyoshi H, Yanagida E, Yoshida N, Kiyasu J, Kozai Y, Morikita T, Kato T, Suzushima H, Tamura S, Muta T, Kato K, Eto T, Seki R, Nagafuji K, Sone H, Takizawa J, Seto M, Ohshima K. Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454 [Abstract] [Full Text] [Related]
15. T-cell chronic lymphocytic leukemia or small-cell variant of T-cell prolymphocytic leukemia: a historical perspective and search for consensus. Rashidi A, Fisher SI. Eur J Haematol; 2015 Sep; 95(3):199-210. PubMed ID: 25846234 [Abstract] [Full Text] [Related]